Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trinity Biotech (TRIBY) -- Ignore unavailable to you. Want to Upgrade?

To: Kevin Ameling who wrote (7325)	11/1/1997 4:07:00 PM
From: Ron Luhmann	Respond to of 14328

this post from the Triby AOL board ... Polly visited Dublin Oct 12-13th Subject: Re: Earnings Date: Sat, Nov 1, 1997 11:20 EST From: PollyBust Message-id: Yes, The HIV test is important, but what your overlooking is the huge potential of their uni-gold platform. Most of the tests that they now have (nearly 100) as well as others, can be adapted to this format, which means inexpensive rapid tests w/ good profit margins. This is where the potential of this company is down the road. They are also looking into puting several tests on the same card, so when a person goes in to get a test for say Hepatitis, he/she can be tested for HIV, herpes, and god knows what else. The # dropped by Trinity when we were there last month was 5 tests at once, so this could be big and give them an advantage over competition. Yes, we all would like to see HIV test come to the US market, but it will not make or break co, long term. It's more important for braking the ice at the FDA for other tests, IMHO.

To: Kevin Ameling who wrote (7325)	11/1/1997 11:06:00 PM
From: Caroline and Daughters	Read Replies (1) \| Respond to of 14328

Kevin I agree with you. IMO the stock price is where it should be, because that is what it is worth. Again IMO the PR firm is a waste of $. I think the Longs were doing what could be done. Proof of the pudding is in the eating and TRIBY is still not tasty enough to be in demand. Granted I think we all have found the morsel before the rest of the masses (or as Karl Marx used to refer to them as the peoples.) There are many companies who routinely moniter the FDA goings on. TV netwroks among them. If TRIBY was as exciting to them as it is to us, I think TRIBY would have been on the evening news and we'd all be salivating at the banks' counters. Another thing is the prevelance of many small investors, let alone bigger ones, who have computer programs that scan for EPS and trend lines and other charting characteristics (BS IMO) especially with no movement. This being a weekend, keicko had issued me a license for being gabby. What will make triby move is one thing more sales and as a corollary a better bottom line, Not dog and pony shows nor spit contests. I too can and will wait, I don't like it but sometimes we all must eat some broccoli. Off Topic My favorite football team the OAKLAND RAIDERS are taking a page from TRIBY's price performance and USING IT for their playbook. GO TRIBY Grunt ( Caroline is testing the oranges for citric acid)

To: Kevin Ameling who wrote (7325)	11/2/1997 11:10:00 PM
From: Scott H. Davis	Respond to of 14328

Thoughts on the market non response. TRIBY did have record revenues, but only met estimates. I've seen a lot of companies fall back despite moderate positive EPS surprises this fall. TRIBY still has a miniscule market cap, and at under 3.00, hardly any fund will touch them. The market can be slow to forgive a disapointment, and the slowness in submissions and FDA slow response was a disapointment. I agree with the with other contributors assessments of the solid foundation and product positioning being built by TRIBY. But based on current fundimentals, it is not undervalued. quote.yahoo.com still shows it with -.02 EPS. WSRN still shows it with a - PM, ROE/ROA. So since it does not work yet as a value play, can't attract funds, and only one analyst following it does not leave TRIBY with a very large pool of investors to interest - today. compare this to a couple micro cap networking stocks I hold EQNX and SBEI. I choose these since their stock fell significantly on disapointments last year, and eventhough they posted a couple better qtrs, the stock price took a long time to recover, but recover they did once the market say enough tangible evidence to support the potential. But looking at the fundimentals today Ask EPS (12 month) PE projected PE curr. qtr/share price TRIBY 2.62 -.02 N/A .0072 EQNX 16.75 .88 18.21 14.83 .0179 SBEI 14.38 .02 18.42 16.47 .0185 Conclusion, don't expect a major jump until either a great anouncement, or TRIBY makes enough progress to show positive balance sheet ratios - EPS, PE, PM. ROA, ROE. Look at what small and mid cap value funds have done this year compared to growth funds. The market still has a value bent. IMO, Scott (patiently long) Remember ISIP and VICL are both still well down from their peaks. They won't challenge old highs either without great news or fundimentals either.